Stay updated on Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the pembrolizumab and radiation study is displayed, including its study design, eligibility criteria, outcomes, completion status, and study documents, replacing the error page.
    Difference
    52%
    Check dated 2026-11-07T12:26:18.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:14:09.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A sitewide notice says NIH websites are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T16:31:45.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The revision identifier in the footer changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T16:18:13.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T16:22:16.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error for the study record, indicating access is blocked. This prevents viewing the study details on this page.
    Difference
    19%
    Check dated 2026-09-19T19:01:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.